Key Points Revolution Medicines has just received good news around a drug meant to treat pancreatic cancer. While the company has multiple drugs in development, buying Revolution Medicines is still basically like putting all of your eggs in one basket. Royalty Pharma lets you spread your bets while still getting exposure to Revolution Medicines' success. 10 stocks we like better than Royalty Pharma Plc › Revolution Medicines (NASDAQ: RVMD) just got some very good news: The FDA gave the company's RASONQUE breakthrough therapy designation. That could help speed the metastatic pancreatic cancer drug to market. But the stock is up 330% over the past year, so investors are already pricing in a lot of good news.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.